Rapid7, Inc. - Common Stock (NQ:RPD)
Price and Volume
Detailed Quote| Volume | 3,148,268 |
| Open | 14.70 |
| Bid (Size) | 14.70 (300) |
| Ask (Size) | 14.93 (200) |
| Prev. Close | 14.73 |
| Today's Range | 14.52 - 15.29 |
| 52wk Range | 4.970 - 19.34 |
| Shares Outstanding | 55,783,467 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
22.9% below 52-week high
14.91
4.9752W Low
19.3452W High
1 Week
2.5% below 1-week high
12.591W Low
15.291W High
Rapid7, Inc. - Common Stock (RPD) traded between $4.97 and $19.34 over the past 52 weeks and last traded at $14.91, 22.9% below its 52-week high. Over the past week it ranged between $12.59 and $15.29.
Past 12 Months
+12.8%
+13.9%
+57.1%
+150.6%
+4.5%
-21.2%
1W
+$1.69
1M
+$1.82
3M
+$5.42
6M
+$8.96
YTD
+$0.64
1Y
-$4.01
RPD was -21.2% over the past year, +150.6% over six months, +4.5% year to date, +12.8% in the last week.
12 Months vs Market
RPD
-21.2%
DIA
+11.6%
SPY
+13.1%
QQQ
+15.4%
IWM
+11.9%
Over the past 12 months RPD returned -21.2% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
1.59× 3-mo avg
Today 3,148,268
3-mo avg 2.0M
1W
1.8M
1M
1.6M
3M
2.0M
6M
2.2M
YTD
2.1M
1Y
1.9M
RPD most recently traded 3,148,268 shares against a 3-month average daily volume of 2.0M.
More News
Read More
From Rapid7
Via GlobeNewswire
Rapid7 to Report Third Quarter 2026 Financial Results on November 4
October 14, 2026
From Rapid7
Via GlobeNewswire
3 Value Stocks We Find Risky
October 12, 2026
Via StockStory
Topics
Retirement
3 Unpopular Stocks with Questionable Fundamentals
October 07, 2026
Via StockStory
From Rapid7
Via GlobeNewswire
3 Russell 2000 Stocks We Find Risky
October 02, 2026
Via StockStory
Topics
Artificial Intelligence
Asana, Unity, C3.ai, Rapid7, and ZoomInfo Shares Are Soaring, What You Need To Know
September 30, 2026
Via StockStory
Qualys, Okta, Palo Alto Networks, Rapid7, and SentinelOne Shares Plummet, What You Need To Know
September 25, 2026
Via StockStory
Topics
Artificial Intelligence
Cybersecurity Stocks Q2 Teardown: Rapid7 (NASDAQ:RPD) Vs The Rest
September 22, 2026
Via StockStory
Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 17, 2026
From Rapid7
Via GlobeNewswire
Why Rapid7 (RPD) Shares Are Falling Today
September 15, 2026
Via StockStory
Topics
Artificial Intelligence
Autodesk, C3.ai, GoDaddy, Rapid7, and Sprout Social Stocks Trade Up, What You Need To Know
September 14, 2026
Via StockStory
Topics
Artificial Intelligence
2 Software Stocks on Our Watchlist and 1 We Ignore
September 03, 2026
Via StockStory
3 Reasons to Avoid RPD and 1 Stock to Buy Instead
September 02, 2026
Via StockStory
Rapid7 (RPD) Q2 2026 Earnings Call Transcript ↗
August 17, 2026
Via The Motley Fool
5 Insightful Analyst Questions From Rapid7’s Q2 Earnings Call
August 17, 2026
Via StockStory
Topics
Earnings
Frequently Asked Questions
Is Rapid7, Inc. - Common Stock publicly traded?
Yes, Rapid7, Inc. - Common Stock is publicly traded.
What exchange does Rapid7, Inc. - Common Stock trade on?
Rapid7, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rapid7, Inc. - Common Stock?
The ticker symbol for Rapid7, Inc. - Common Stock is RPD on the Nasdaq Stock Market
What is the current price of Rapid7, Inc. - Common Stock?
The current price of Rapid7, Inc. - Common Stock is 14.91
When was Rapid7, Inc. - Common Stock last traded?
The last trade of Rapid7, Inc. - Common Stock was at 10/23/26 04:00 PM ET
What is the market capitalization of Rapid7, Inc. - Common Stock?
The market capitalization of Rapid7, Inc. - Common Stock is 831.73M
How many shares of Rapid7, Inc. - Common Stock are outstanding?
Rapid7, Inc. - Common Stock has 832M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>